Lakefront Biotherapeutics GXE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Lakefront Biotherapeutics is a clinical-stage biotechnology company focused on the discovery and development of small molecule therapies targeting unmet medical needs. Headquartered in Belgium, it operates in the healthcare sector, leveraging advanced research to advance innovative treatments through preclinical and cl…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryBelgium
Employees558
TickerGXE
Statistics
Market Cap$1.90B
Revenue (TTM)$1.19B
Net Income—
Net Margin—
EPS—
P/E3.40
P/S1.59
P/B0.51
EV/EBITDA-1.99
ROE16.3%
Dividend Yield—
Price$28.79
Data: Twelve Data · Revenue = mcap / P/S